6.51  0.36 (5.85%)		04-30 16:00
Open: 6.19 High: 6.64 Volume: 79,548		Pre. Close: 6.15 Low: 5.97 Market Cap: 53(M)

Short term
Mid term
Targets	6-month :	7.88	1-year :	8.7
Resists	First :	6.75	Second :	7.44
Pivot price	6.32
Supports	First :	5.61	Second :	4.67
MAs	MA(5) :	6.22	MA(20) :	6.41
	MA(100) :	6.11	MA(250) :	5.73
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	38.7	D(3) :	30.5
RSI	RSI(14): 52.7
52-week	High :	8.64	Low :	4.15

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ECOR ] has closed below upper band by 28.6%. Bollinger Bands are 55.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	6.65 - 6.68	6.68 - 6.7
Low:	5.91 - 5.94	5.94 - 5.96
Close:	6.46 - 6.51	6.51 - 6.56

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Thu, 30 Apr 2026
National Safety Council names electroCore fatigue tool semifinalist - Stock Titan

Wed, 29 Apr 2026
electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026 - GlobeNewswire

Tue, 28 Apr 2026
electroCore to Present at the Market Movers Investor Summit on May 5, 2026 - GlobeNewswire

Tue, 28 Apr 2026
On May 5, electroCore's interim president and CFO presents in NYC - Stock Titan

Tue, 28 Apr 2026
electroCore to Present at the Market Movers Investor Summit on May 5, 2026 - ChartMill

Sun, 26 Apr 2026
ElectroCore FY earnings preview - MSN

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	8 (M)
Shares Float	5 (M)
Held by Insiders	37.1 (%)
Held by Institutions	10.2 (%)
Shares Short	292 (K)
Shares Short P.Month	262 (K)

EPS	-1.65
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.21
Profit Margin	-43.6 %
Operating Margin	-31.9 %
Return on Assets (ttm)	-42.1 %
Return on Equity (ttm)	-478.8 %
Qtrly Rev. Growth	31.2 %
Gross Profit (p.s.)	3.43
Sales Per Share	3.96
EBITDA (p.s.)	-1.57
Qtrly Earnings Growth	0 %
Operating Cash Flow	-8 (M)
Levered Free Cash Flow	-3 (M)

PE Ratio	-3.95
PEG Ratio	0
Price to Book value	-31.01
Price to Sales	1.64
Price to Cash Flow	-6.43

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.